The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer


This activity is intended for hematologists, medical oncologists, urologists and other healthcare providers involved in the treatment of urothelial bladder carcinoma.

Once registered, you will receive an email with specific instructions including a link to use on the day of the event to log in and view the webinar. A link will be provided for access to a CME credit form within 5 days after the meeting.

SUBMIT CHALLENGING CASES AND QUESTIONS
Dr Neil Love and the faculty for this program would like to encourage participants to submit challenging cases and questions for discussion during the webinar. You are also welcome to email your detailed case(s) and/or questions ahead of the program, including any accompanying images/pathology. You may email us at Meetings@ResearchToPractice.com or submit a case or question during your registration below.

Meeting Information
LIVE WEBINAR

Thursday, July 9, 20205:00 PM – 6:00 PM ET

Personal Information

Please choose your highest degree

Mailing Address

Submit your case or question here for our panelists to address during the webinar.